Motixafortide Clinical Trials

3 actively recruiting trials across 3 locations

▲ +1 trial since July 2026

Also known as: 4F-Benzoyl-TN14003, Aphexda, BKT 140, BKT-140, BKT140 +6 more

Pipeline

Phase 2: 2Phase 4: 1

Top Sponsors

Washington University School of Medicine1
Gulam Manji1
Emory University1

Indications

Cancer3
Measurable Residual Disease1
Adenocarcinoma of the Pancreas1
Adenocarcinoma1
Acute Myeloid Leukemia1

Atlanta, Georgia1 trial

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Emory University Hospital/Winship Cancer Institute

Phase 4

St Louis, Missouri1 trial

Motixafortide for MRD Sensitization in AML

Washington University School of Medicine

Phase 2

New York, New York1 trial

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Columbia University Irving Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.